Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Journal of Virology
|
June 20, 2024
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model
Christiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 8, 2023
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system
Philipp Reus, Hadar Guthmann, Nadja Uhlig, et al.
Scientific Reports
|
October 24, 2020
Publisher Correction: Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
Jasmin Fertey, Martin Thoma, Jana Beckmann, et al.
Scientific Reports
|
August 1, 2020
Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
Jasmin Fertey, Martin Thoma, Jana Beckmann, et al.
Communications Biology
|
July 15, 2024
Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2
Jannik T Wagner, Sandra M Müller-Schmucker, Wenjun Wang, et al.
Brain Pathology (Zurich, Switzerland)
|
January 11, 2016
Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity
Johannes Schurr, Roland Coras, Karl Rössler, et al.
Nature Communications
|
November 27, 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Dennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Iscience
|
May 2, 2022
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
Kim M Stegmann, Antje Dickmanns, Natalie Heinen, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
Alexandra Herrmann, Friedrich Hahn, Christina Wangen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 11, 2022
Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2
Rüdiger Groß, Lívia Mesquita Dias Loiola, Leila Issmail, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Journal of Virology
|
June 20, 2024
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model
Christiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 8, 2023
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system
Philipp Reus, Hadar Guthmann, Nadja Uhlig, et al.
Scientific Reports
|
October 24, 2020
Publisher Correction: Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
Jasmin Fertey, Martin Thoma, Jana Beckmann, et al.
Scientific Reports
|
August 1, 2020
Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
Jasmin Fertey, Martin Thoma, Jana Beckmann, et al.
Communications Biology
|
July 15, 2024
Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2
Jannik T Wagner, Sandra M Müller-Schmucker, Wenjun Wang, et al.
Brain Pathology (Zurich, Switzerland)
|
January 11, 2016
Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity
Johannes Schurr, Roland Coras, Karl Rössler, et al.
Nature Communications
|
November 27, 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Dennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Iscience
|
May 2, 2022
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
Kim M Stegmann, Antje Dickmanns, Natalie Heinen, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
Alexandra Herrmann, Friedrich Hahn, Christina Wangen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 11, 2022
Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2
Rüdiger Groß, Lívia Mesquita Dias Loiola, Leila Issmail, et al.
Page
of 13